ATX
Click for more information
3.33% 6.2¢ amplia therapeutics limited

Ann: Amplia Initiates Multiple Dose Study of AMP945, page-2

  1. Bobox
    340 Posts.
    lightbulb Created with Sketch. 74
    clock Created with Sketch.
    17/02/21
    08:29
    Post #: 51059544
    Great work. The clear objective of making timely progress is reassuring, as is the absence of any adverse reactions (the endpoint of a phase 1 trail).
    ATX Price at posting: 27.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.2¢ 		Change
0.002(3.33%) 		Mkt cap ! $16.83M
Open High Low Value Volume
6.1¢ 6.3¢ 6.1¢ $36.73K 593.4K

Buyers (Bids)

No. Vol. Price($)
1 56034 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 195711 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.